Ryvu Therapeutics Dividends and Buybacks
Dividend criteria checks 0/6
Ryvu Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Despite Lacking Profits Ryvu Therapeutics (WSE:RVU) Seems To Be On Top Of Its Debt
Oct 20
We're Keeping An Eye On Ryvu Therapeutics' (WSE:RVU) Cash Burn Rate
Aug 02Are Investors Undervaluing Ryvu Therapeutics S.A. (WSE:RVU) By 20%?
Jan 25What Type Of Shareholders Own The Most Number of Ryvu Therapeutics S.A. (WSE:RVU) Shares?
Feb 05Shareholders Of Ryvu Therapeutics (WSE:RVU) Must Be Happy With Their 261% Total Return
Dec 14Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if RVU's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RVU's dividend payments have been increasing.
Dividend Yield vs Market
| Ryvu Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RVU) | n/a |
| Market Bottom 25% (PL) | 2.9% |
| Market Top 25% (PL) | 8.1% |
| Industry Average (Life Sciences) | 0.7% |
| Analyst forecast (RVU) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate RVU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RVU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate RVU's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as RVU has not reported any payouts.